Integer Holdings Corp (ITGR) · Sep 30, 2026 · Acquisition
HSR cleared — HSR waiting period terminated; $127-per-share cash merger remains subject to approval
Integer’s acquisition filing confirms HSR clearance for KKR’s $5.7 billion take-private deal, with the October 21 shareholder vote still ahead.
Integer is a medical-device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets; its immediate business story is now dominated by KKR’s announced take-private transaction rather than a new operating initiative.
The deal clears one regulatory hurdle, but the economics do not change. Early termination of the HSR waiting period satisfies one closing condition. 〔0〕 The consideration remains $127 per share in cash, representing approximately $5.7 billion of enterprise value.
This is progress, not a surprise reset. HSR clearance was a customary and anticipated step in the previously announced merger, so the filing reduces execution uncertainty modestly without changing the offer price, strategic rationale, or expected closing window. Other antitrust and foreign-investment approvals, along with stockholder approval, remain outstanding. 〔1〕
The next gating event is now clearly scheduled. Integer’s virtual special meeting is set for October 21, 2026, and the board continues to recommend that stockholders vote for the merger. 〔2〕
Bottom line: The filing confirms the KKR transaction is advancing normally, but it does not materially change the standing deal story. The shareholder vote and remaining regulatory approvals are still the meaningful execution steps.
Shareholder vote on merger, October 21, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!